https://charts.traderzeitung.de/phases/US29089Q1058
string(1401) "{"isin":"US29089Q1058","name":"Emergent BioSolutions Inc","stock_id_xnas":null,"stock_id_xnys":7871714,"generated_at":"2026-07-21 03:47:00","days":[{"date":"2026-07-16","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.69,"close_at":"2026-07-16 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-17","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.625,"close_at":"2026-07-17 21:59:00","complete":true,"perf_pct":-0.8453},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.683,"close_at":"2026-07-20 21:59:00","complete":true,"perf_pct":0.7607},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Emergent Biosolutions Aktie News & Nachrichten

Emergent Biosolutions Aktie News & Nachrichten

[WKN: A0LC2W | Symbol: EBS]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Emergent Biosolutions Chart

Artikel aus der Redaktion der Trader-Zeitung

Emergent BioSolutions: Fokus auf Mpox und die Opioid-Krise

Emergent BioSolutions ist ein US-amerikanisches Biopharmaunternehmen, das sich auf die Entwicklung und...

  • 1
MT Newswires 29.06.2026 16:32 Uhr

Emergent erhält 52,7 Millionen US-Dollar Vertragsänderung von der US-Regierung

10:31 AM EDT, 06/29/2026 (MT Newswires) -- Emergent BioSolutions (EBS) teilte am Montag mit, dass es eine Vertragsänderung im Wert von 52,7 Millionen

MT Newswires 28.05.2026 23:32 Uhr

Emergent BioSolutions erhält Vertragsänderung der US-Regierung über 64,5 Millionen US-Dollar für BAT

05:31 PM EDT, 05/28/2026 (MT Newswires) -- Emergent BioSolutions (EBS) teilte am Donnerstag mit, dass ihr eine Vertragsänderung im Wert von etwa 64,5